CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 181 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,200,865 | +330.8% | 30,279 | +198.9% | 0.00% | +100.0% |
| Q3 2023 | $278,778 | -29.4% | 10,130 | -13.0% | 0.00% | 0.0% |
| Q2 2023 | $394,877 | +51.4% | 11,638 | +98.8% | 0.00% | – |
| Q4 2022 | $260,868 | -57.5% | 5,853 | -73.2% | 0.00% | -100.0% |
| Q3 2022 | $614,000 | +4.4% | 21,843 | +0.1% | 0.00% | -50.0% |
| Q2 2022 | $588,000 | -65.8% | 21,811 | -56.8% | 0.00% | -66.7% |
| Q1 2022 | $1,719,000 | +14.9% | 50,487 | +82.1% | 0.01% | +20.0% |
| Q3 2021 | $1,496,000 | +976.3% | 27,718 | +158.7% | 0.01% | – |
| Q2 2020 | $139,000 | – | 10,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,388,967 | $125,425,669 | 9.68% |
| 5AM Venture Management, LLC | 497,270 | $18,403,963 | 4.12% |
| COMMODORE CAPITAL LP | 1,425,000 | $52,739,250 | 3.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 374,910 | $13,875,419 | 3.27% |
| TSP Capital Management Group, LLC | 249,220 | $9,223,635 | 2.89% |
| Eventide Asset Management | 3,327,132 | $123,137,155 | 2.11% |
| Affinity Asset Advisors, LLC | 475,400 | $17,594,554 | 2.03% |
| Novo Holdings A/S | 850,000 | $31,458,500 | 1.83% |
| Bellevue Group AG | 2,971,615 | $109,979,471 | 1.79% |
| Redmile Group, LLC | 718,723 | $26,599,938 | 1.61% |